The effectiveness of harm reduction in preventing HIV among injecting drug users
Open Access
- 27 May 2010
- journal article
- Published by CSIRO Publishing in New South Wales Public Health Bulletin
- Vol. 21 (4) , 69-73
Abstract
There is now compelling evidence that harm reduction approaches to HIV prevention among injecting drug users are effective, safe and cost-effective. The evidence of effectiveness is strongest for needle and syringe programs and opioid substitution treatment. There is no convincing evidence that needle and syringe programs increase injecting drug use. The low prevalence (∼1%) of HIV among injecting drug users reflects the early adoption and rapid expansion of harm reduction in Australia. Countries that have provided extensive needle and syringe programs and opioid substitution treatment appear to have averted an epidemic, stabilised or substantially reduced the prevalence of HIV among injecting drug users. However, despite decades of vigorous advocacy and scientific evidence, the global coverage of needle and syringe programs and opioid substitution treatment falls well short of the levels required to achieve international HIV control.Keywords
This publication has 32 references indexed in Scilit:
- The role of harm reduction in controlling HIV among injecting drug usersAIDS, 2008
- Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviorsJournal of Substance Abuse Treatment, 2008
- A Randomized Intervention Trial to Reduce the Lending of Used Injection Equipment Among Injection Drug Users Infected With Hepatitis CAmerican Journal of Public Health, 2008
- Syringe possession arrests are associated with receptive syringe sharing in two Mexico–US border citiesAddiction, 2007
- A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug usersAIDS, 2007
- Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, AustraliaDrug and Alcohol Dependence, 2007
- Policing and public health: Law enforcement and harm minimization in a street-level drug marketThe British Journal of Criminology, 1999
- Methadone treatment as a determinant of HIV risk reduction among injecting drug users: A nested case-control studyAIDS Care, 1994
- HIV seroconversion in intravenous drug users in San Francisco, 1985–1990AIDS, 1994
- Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug usersAIDS Care, 1992